AspenBio Pharma Reports on FDA 510(k) Clinical Trial Progress for ... MarketWatch - As of November 17, 2008, there were 701 patients enrolled in the ongoing clinical trial in which 800 patient enrollments will complete the study. ... |
« Competitive Technologies to Display Pain Management Medical Device ... - MarketWatch | Main | Immunosyn Corporation Files 10-Q - Ad-Hoc-News (Pressemitteilung) »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f12088330105362d5ec3970c
Listed below are links to weblogs that reference AspenBio Pharma Reports on FDA 510(k) Clinical Trial Progress for ... - MarketWatch:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments